What is Antimicrobial Resistance?

Antimicrobial resistance (AMR) is complex problem threatening modern medicine, creating the potential for even a routine procedure to become life threatening. AMR occurs when bacteria, fungi, viruses, and parasites mutate naturally over time and no longer respond to modern medicines— a problem exacerbated by the misuse and overuse of antimicrobials.


 

a woman wearing a labcoat and stethoscope sits at a conference table with a report in front of her; in the background a man in scrubs, standing, confers with a man in a labcoat sitting at the conference table and reviewing a laptop screen

Antimicrobial Resistance is the Problem. Antimicrobial Stewardship is the Solution.

According to the National Institute for Health and Care Excellence’s NICE guideline (NG15):“The term ‘antimicrobial stewardship’ is defined as ‘an organisational or health-care-system-wide approach to promoting and monitoring judicious use of antimicrobials to preserve their future effectiveness’.”

The goal of AMS programmes, is to ensure that the right antibiotic is given to the right patient at the right time, with the right dose and via the right route— causing the least harm to the patient.

You Can Make a Difference in the Fight Against AMR

Get Started Today

Diagnostics Are At The Heart Of Antimicrobial Stewardship

The uncertainty of diagnosis is one of the key drivers of antimicrobial overuse and misuse. Therefore, diagnostic tests are instrumental for AMS initiatives since they can have a decisive impact on clinical decision-making and outcomes.

Putting diagnostics at the heart of AMS helps you drive informed therapy decisions from antibiotic initiation to optimisation and discontinuation. High medical value diagnostics and data-driven solutions can be used to provide you faster, more optimised antibiotic therapy guidance, to help improve patient outcomes and reduce hospital costs.

  • Achieve rapid and accurate identification of pathogens
  • Differentiate between bacterial and viral infections
  • Gain knowledge of antimicrobial susceptibility testing (AST)
  • Support better clinical decision-making

Antimicrobial Stewardship:

The Value of Diagnostics to Optimise Antimicrobial Therapy & Patient Care

The global overuse and misuse of antibiotics continues at varying degrees and collectively threatens patient health and the financial stability of healthcare systems. bioMérieux explores how diagnostic stewardship and AMS can help to optimise antimicrobial therapy and improve patient care in this exclusive article.

Read This Site Exclusive Article

Our Complete Integrated Solution for Antimicrobial Stewardship

 

bioMérieux provides the most complete solution to support AMS initiatives with 80% of our product portfolio dedicated to the against AMR. Our actionable diagnostics paired with complementary advanced analytics, collaborative services and educational modules, enable clinicians to provide earlier, optimised and data-driven therapy for better patient management and responsible antibiotic use throughout the entire patient care pathway.

Infographic breaking bioMérieux diagnostic products into categories based on what stage of the Antimicribial Stewardship pathway they address

YOU CAN HELP MAKE A DIFFERENCE IN THE FIGHT AGAINST ANTIMICROBIAL RESISTANCE

Get Started Today

Ward rounds support antimicrobial stewardship initiatives

Data concludes that AMS is critically important with the frequent overuse and misuse of broad-spectrum antibiotics.

Evidence indicates that AMS ward rounds can be pivotal in optimising patient antibiotic treatment by switching patients from IV to oral antibiotics, ensuring they're on the correct antibiotics, and aiding in the discontinuation of antibiotic treatment sooner to help limit the instance of adverse health outcomes. Surveys indicate that AMS ward rounds also helps to improve workflows by allowing time-savings.

Everyone Has a Role to Play In Fighting Antimicrobial resistance

Register to receive actionable information about how to optimise the use of diagnostics and data to improve patient management and slow the spread of AMR.

1Thompson T. The staggering death toll of drug-resistant bacteria. Nature. Published online January 31, 2022. doi:https://doi.org/10.1038/d41586-022-00228-x

Our Diverse Resources Support Your Stewardship Initiatives

Discover how our rapid diagnostic solutions can support timely detection and identification for optimised antibiotic therapy and improved patient outcomes.

illustrated icon of a compass

Explore on-demand information, timely thought leadership, and diagnostic solutions supporting the fight against AMR.

illustrated icon of a computer screen displaying an open book

Listen to clinical insights and interviews with microbiology experts about the value of diagnostics.

« Return to Top

The Value of Diagnostics to Optimise Antimicrobial Therapy & Patient Care

Access Andrea Prinzi's Editorial